Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% | 0.00% | -92.00% |
2022 | DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction. | CI |
2016 | Oncologix Tech, Inc. Announces Management Changes | CI |
Sales 2013 | 0.24 19.22 | Sales 2014 | 3.68 289.43 | Capitalization | 758K 59.66M |
---|---|---|---|---|---|
Net income 2013 | - 0 | Net income 2014 | -1M -78.7M | EV / Sales 2013 | 8,716,069 x |
Net Debt 2013 | 1.33M 104M | Net Debt 2014 | 1.89M 149M | EV / Sales 2014 | 721,342 x |
P/E ratio 2013 |
-1.03
x | P/E ratio 2014 |
-0.47
x | Employees | 191 |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 99% |
3 months | +100.00% | ||
6 months | -75.00% | ||
Current year | -92.00% |
Managers | Title | Age | Since |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 24/06/21 |
Nikole Jessie
IRO | Public Communications Contact | - | 31/05/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 24/06/21 |
1st Jan change | Capi. | |
---|---|---|
-92.00% | 332K | |
+186.86% | 7.13B | |
+2.10% | 982M | |
+41.91% | 872M | |
+26.00% | 820M | |
+1.72% | 664M | |
+5.92% | 648M | |
-.--% | 600M | |
+3.61% | 503M | |
-.--% | 500M |
- Stock Market
- Equities
- OCLG Stock